Simplex Trading, LLC Adicet Bio, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 6,423 shares of ACET stock, worth $5,716. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,423

Holding current value

$5,716

% of portfolio

0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$1.07 - $1.63 $6,872 - $10,469	6,423 New	6,423 $9,000
Q4 2023 Feb 02, 2024	BUY	$1.11 - $1.89 $1,769 - $3,012	1,594 Added 10.67%	16,540 $31,000
Q3 2023 Nov 01, 2023	BUY	$1.37 - $3.4 $19,467 - $48,314	14,210 Added 1930.71%	14,946 $20,000
Q2 2023 Aug 04, 2023	SELL	$2.13 - $7.13 $4,632 - $15,507	-2,175 Reduced 74.72%	736 $1,000
Q1 2023 Apr 27, 2023	BUY	$5.52 - $9.23 $16,068 - $26,868	2,911 New	2,911 $16,000
Q3 2022 Nov 04, 2022	BUY	$13.43 - $18.74 $207,547 - $289,607	15,454 New	15,454 $219,000
Q2 2022 Aug 03, 2022	SELL	$10.26 - $20.81 $12,558 - $25,471	-1,224 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$11.53 - $19.97 $180,686 - $312,949	-15,671 Reduced 92.76%	1,224 $24,000
Q4 2021 Feb 23, 2022	BUY	$7.37 - $17.49 $115,672 - $274,505	15,695 Added 1307.92%	16,895 $295,000
Q2 2021 Aug 12, 2021	BUY	$9.19 - $15.93 $11,028 - $19,116	1,200 New	1,200 $12,000

Others Institutions Holding ACET

# of Institutions

Shares Held

59.2M

Call Options Held

4.2K

Put Options Held

6.7K

Orbimed Advisors LLC San Diego, CA

11.4M
Shares

$10.2 Million
0.39% of portfolio
Tang Capital Management LLC San Diego, CA

8.22M
Shares

$7.31 Million
1.01% of portfolio
Ra Capital Management, L.P. Boston, MA

7.54M
Shares

$6.71 Million
0.15% of portfolio
Goldman Sachs Group Inc New York, NY

3.76M
Shares

$3.35 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.21M
Shares

$2.85 Million
0.0% of portfolio

View Full List

About Adicet Bio, Inc.

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $35.6M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

More about ACET

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account